71-80 Round-Up
Quick summaries of our last 10 articles, for busy people.
71. Buprenorphine and Dental Problems
72. Symptom-Triggered Alcohol Withdrawal Management Over
Telemedicine
73. Long-Term Opioid Use After a First Prescription
74. Quick-Start Injectable Buprenorphine
75. Contingency Management for Stimulant Use Disorder and
Mortality
76. Injectable Buprenorphine in Pregnancy
77. Epic’s Opioid Risk Score
78. Treating Alcohol Use Disorder in Patients with Severe Liver Disease
79. Direct-to-Inject Buprenorphine
80. Phenobarbital for Alcohol Withdrawal
Full citations, for those who love references:
Tuan WJ, Clebak KT, Jawadi E, Snyder J, Zgierska AE. Risk of Oral Health Problems in Adults With Opioid Use Disorder Treated With
Transmucosal Buprenorphine. J Addict Med. 2025
Sep-Oct 01;19(5):529-535. doi: 10.1097/ADM.0000000000001453. Epub 2025 Mar 10. PMID: 40062592.
Sloan ME, Ngoy A, Xiao KB, Barker B, Buckley L, Fodor M, Hardy K, Hendershot CS, Kahan M, La Fleur S, Le Foll B, Manicone M, Sanches M, Simpkin E, Quilty LC, Wyman J, Tang VM, Bozinoff N. Symptom-Triggered
Alcohol Withdrawal Management Delivered Over Telemedicine.
J Addict Med. 2025 Nov-Dec 01;19(6):708-715. doi: 10.1097/ADM.0000000000001491.
Epub 2025 May 1. PMID: 40310714; PMCID: PMC12352377.
Smith AM, Shah A, Martin BC. An updated view
on the influence of initial opioid prescription characteristics on long-term
opioid use among opioid naïve patients. Drug Alcohol Depend. 2024
Dec 1;265:112463. doi: 10.1016/j.drugalcdep.2024.112463. Epub 2024 Oct 24. PMID: 39549364; PMCID: PMC11924105.
Shiwach R, Le Foll B, Alho H, Dunn KE, Strafford S, Zhao Y, Dobbins RL. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2025 Oct 1;8(10):e2537319. doi: 10.1001/jamanetworkopen.2025.37319. PMID: 41085986; PMCID: PMC12522003.
Coughlin LN, Tomlinson DC, Zhang L, Kim HM, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study. Am J Psychiatry. 2025 Nov 1;182(11):1016-1023. doi: 10.1176/appi.ajp.20250053. Epub 2025 Sep 10. PMID: 40926572.
Winhusen TJ, Lofwall MR, Kropp F, Lewis D, Smid MC, Young JL, Hodgkins C, Krans EE, Hansen Z, Wachman EM, Schiff DM, Guille C, Rudolf V, Chowdhury T, Leeman L, Lewis M, Matthews AG, Cochran G, King J, Wilder C, Rosa C. Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial. JAMA
Intern Med. 2026 May 1;186(5):533-543. doi: 10.1001/jamainternmed.2026.0057.
Hooker SA, Rossom RC, Haapala J, Crain AL, Miley K, Olson AW, Kane S, Christensen K, O'Connor PJ, Bart G, Wright EA. External
Validation of Epic's Risk of Opioid Abuse and Overdose Model Among Primary Care Patients in Three Health Systems. J Gen Intern Med. 2026 Feb 17. doi: 10.1007/s11606-026-10257-1. Epub ahead of print. PMID: 41703383.
Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open. 2026 Feb 2;9(2):e2559016. doi: 10.1001/jamanetworkopen.2025.59016. PMID: 41670995; PMCID: PMC12895287.
Rosenwohl-Mack S, Heeney M, Samuel L, Anderson E, Herring AA, Sirey LR, Peterson D, Bazazi AR, Snyder H, Suen LW. Outpatient initiation of direct-to-inject buprenorphine. Drug Alcohol Depend. 2026 Jan 1;278:113011. doi: 10.1016/j.drugalcdep.2025.113011. Epub 2025 Dec 19. PMID: 41442975; PMCID: PMC13271074.
Wolpaw BJ, Oren H, Quinnan-Hostein L, Bradley KA, Johnson NJ, Hallgren KA, Gupta A, Kim HN, Granich MA, Steel TL. Hospital-Wide Implementation, Clinical Outcomes, and Safety of Phenobarbital for Alcohol Withdrawal. JAMA Netw Open. 2025 Aug 1;8(8):e2528694. doi: 10.1001/jamanetworkopen.2025.28694. PMID: 40853658; PMCID: PMC12379078.
---
This episode does not offer CME, but others do. You can
get category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. Go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.
CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/
---
Original theme music: composed and performed by Benjamin Kennedy
Audio editing: Michael Bonanno
Executive producer: Dr. Patrick Beeman
A podcast from Ars Longa Media
---
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
---
Email: addictionmedicinejournalclub@gmail.com
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
Instagram: @AddictionMedJC
Threads: @AddictionMedJC
YouTube: addictionmedicinejournalclub
Twitter/X: @AddictionMedJC
---
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
